U.S. adds only 210,000 jobs in November, below expectations

The U.S. jobs report for November has come in significantly under expectations.
The Labor Department said Friday the United States economy added 210,000 jobs in November, and the unemployment rate declined to 4.2 percent. The number of jobs gained fell short of economists' expectations that 573,000 would be added, according to CNBC.
This came after the jobs report for October surpassed expectations, as 531,000 jobs were added; that was around 100,000 more than expected. The October number was revised up on Friday to 546,000.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In November, "notable job gains occurred in professional and business services, transportation and warehousing, construction, and manufacturing," the Labor Department said. Retail employment declined. Overall, the economy added the smallest number of jobs since December 2020, CNN notes. While the job gains disappointed, The New York Times notes the household survey indicated the number of employed Americans increased by over 1.1 million.
The report comes amid concerns about the new Omicron variant of COVID-19, though this employment data was obtained before the variant was first identified in the United States. Glassdoor Senior Economist Daniel Zhao wrote that the November report painted a "mixed picture," pointing to the fact that job growth slowed but the unemployment rate "significantly" declined. But he also noted that it presented "a conundrum to policymakers who were hoping for a report providing confidence in labor market health."
Indeed economic research director Nick Bunker also told CNBC, "The underlying momentum of the labor market is still strong, but this month shows more uncertainty than expected."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
6 grand homes in Boulder
Feature Featuring a mountain-facing balcony in Lower Chautauqua and a clover-shaped home in Flagstaff
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published